BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 26270944)

  • 1. Prescription contraception use: a cross-sectional population study of psychosocial determinants.
    Molloy GJ; Sweeney LA; Byrne M; Hughes CM; Ingham R; Morgan K; Murphy AW
    BMJ Open; 2015 Aug; 5(8):e007794. PubMed ID: 26270944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Qualitative Study of Prescription Contraception Use: The Perspectives of Users, General Practitioners and Pharmacists.
    Sweeney LA; Molloy GJ; Byrne M; Murphy AW; Morgan K; Hughes CM; Ingham R
    PLoS One; 2015; 10(12):e0144074. PubMed ID: 26633191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postpartum contraception: initiation and effectiveness in a large universal healthcare system.
    Brunson MR; Klein DA; Olsen CH; Weir LF; Roberts TA
    Am J Obstet Gynecol; 2017 Jul; 217(1):55.e1-55.e9. PubMed ID: 28257962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contraceptive method mix and preference: A focus on long acting reversible contraception in Urban Cameroon.
    Ajong AB; Njotang PN; Kenfack B; Essi MJ; Yakum MN; Iballa FBS; Mbu ER
    PLoS One; 2018; 13(8):e0202967. PubMed ID: 30138474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profile of long-acting reversible contraception users in Europe.
    Haimovich S
    Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):187-95. PubMed ID: 19565416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers to contraception and interest in over-the-counter access among low-income women: a qualitative study.
    Dennis A; Grossman D
    Perspect Sex Reprod Health; 2012 Jun; 44(2):84-91. PubMed ID: 22681423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
    Chiles DP; Roberts TA; Klein DA
    Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-acting reversible contraceptive use in the post-abortion period among women seeking abortion in mainland China: intentions and barriers.
    Luo Z; Gao L; Anguzu R; Zhao J
    Reprod Health; 2018 May; 15(1):85. PubMed ID: 29793501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
    Hubacher D; Spector H; Monteith C; Chen PL; Hart C
    Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knowledge of non-contraceptive benefits of and willingness to consider taking oral contraceptive pills among a low-risk female population: a cross-sectional study.
    O'Hara CA; Shan TW; Yau JNS
    Eur J Contracept Reprod Health Care; 2024 Apr; 29(2):53-60. PubMed ID: 38284986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrauterine Contraception Continuation in Adolescents and Young Women: A Systematic Review.
    Usinger KM; Gola SB; Weis M; Smaldone A
    J Pediatr Adolesc Gynecol; 2016 Dec; 29(6):659-667. PubMed ID: 27386754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contraceptive discontinuation and pregnancy postabortion in Nepal: a longitudinal cohort study.
    Puri M; Henderson JT; Harper CC; Blum M; Joshi D; Rocca CH
    Contraception; 2015 Apr; 91(4):301-7. PubMed ID: 25553872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use pattern for contraceptive implants in Norway.
    Øvre-Eide V; Skjeldestad FE
    Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1244-1250. PubMed ID: 27538540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge of and concerns about long-acting reversible contraception among women in medication-assisted treatment for opioid use disorder.
    Matusiewicz AK; Melbostad HS; Heil SH
    Contraception; 2017 Nov; 96(5):365-369. PubMed ID: 28778423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hormonal ring. A new contraceptive gains acceptance.
    Hardy EE; Reyes Q; Gomez F; Portes-carrasco R; Faundes A
    IDRC Rep; 1984 Jul; 13(2):11. PubMed ID: 12313242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception.
    Cromer BA; Smith RD; Blair JM; Dwyer J; Brown RT
    Pediatrics; 1994 Nov; 94(5):687-94. PubMed ID: 7936897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
    Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
    Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contraceptive prescription: physician beliefs, attitudes and socio-demographic characteristics.
    Russell ML; Love EJ
    Can J Public Health; 1991; 82(4):259-63. PubMed ID: 1954593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns and determinants of modern contraceptive discontinuation among women of reproductive age: Analysis of Kenya Demographic Health Surveys, 2003-2014.
    Ontiri S; Were V; Kabue M; Biesma-Blanco R; Stekelenburg J
    PLoS One; 2020; 15(11):e0241605. PubMed ID: 33151972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-use of Contraception by Canadian Youth Aged 15 to 24: Findings From the 2009-2010 Canadian Community Health Survey.
    Dunn S; Xiong AQ; Nuernberger K; Norman WV
    J Obstet Gynaecol Can; 2019 Jan; 41(1):29-37. PubMed ID: 30316712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.